TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Wed May 20

NL

Article

gbudwell published an article 11:19 AM

Why Shares of Sarepta Therapeutics Skyrocketed Today

Shares of the clinical-stage biotech Sarepta Therapeutics bolted higher by over 50% today. Here's why.

NL

Article

gbudwell published an article 4:54 AM

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Tue May 19

NL

Article

gbudwell published an article 7:45 AM

Uh-Oh! Billionaire George Soros Just Stepped on Another Biotech Landmine

George Soros is one of the most closely watched figures in the investing world. Retail investors, though, shouldn't necessarily take cues from his hedge fund. Here's why.

Sun May 17

NL

Article

gbudwell published an article 10:29 PM

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Fri May 15

NL

Article

gbudwell published an article 3:17 AM

Is Gilead Sciences Its Own Worst Enemy?

Gilead Sciences has an amazing track record of bringing game-changing new drugs to market. Could this unique ability also be the company's biggest weakness?

Thu May 14

NL

Article

gbudwell published an article 9:46 PM

How Celgene Stock Is Breaking All the Rules

Celgene Corp. might look grossly overvalued based on its fundamentals. But a deeper look inside the company shows why the stock remains a compelling buy, despite its monstrous five-year run.

NL

Article

gbudwell published an article 6:51 AM

This Experimental Drug Could Finally Cure HIV

Gilead Sciences is developing an experimental drug that could lead to a functional cure for HIV. Here's what you need to know right now.

NL

Article

gbudwell published an article 12:20 AM

Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar?

Gilead Sciences is on the the prowl for potential buyout targets. This little-known immuno-therapy company looks like a perfect match for the biotech in many ways. Here's why.

Wed May 13

NL

Article

gbudwell published an article 11:25 AM

Why Shares of Orexigen Therapeutics, Inc. Cratered Today

Orexigen Therapeutics is crashing today following more bad news for its diet pill Contrave. Here's what investors need to know right now.

NL

Article

gbudwell published an article 4:25 AM

2 Stocks With Jaw-Dropping Growth Potential

These 2 companies are high-risk investments, but they nonetheless have the potential to become pivotal players in the rapidly expanding field of immuno-oncology. Here's why.

Tue May 12

NL

Article

gbudwell published an article 11:54 AM

Why Shares of Threshold Pharmaceuticals Inc. Broke Higher Today

Shares of the clinical-stage biopharma Threshold Pharmaceuticals shot higher today. Here's why.

NL

Article

gbudwell published an article 11:01 AM

Why Shares of DepoMed Inc. Sank Today

Shares of the specialty drugmaker DepoMed Inc. fell by double-digits today. Here's why.

NL

Article

gbudwell published an article 9:51 AM

Big Pharma Stocks: Where to Invest Your Money Now

We asked three of our healthcare analysts to discuss which Big Pharma stock is worth investing in right now. Here's what they had to say.

Mon May 11

NL

Article

gbudwell published an article 7:00 AM

Which of These Growth Stocks Is Most Worthy of Your Money?

Amarin Corp. and Arena Pharmaceuticals were once high-flying biotech stocks. Since the commercial launch of their respective flagship products, though, their shares have fallen in a big way. In this article, I consider which stock has the better [more]

Sun May 10

NL

Article

gbudwell published an article 8:50 PM

Better Dividend Stock: Pfizer, Inc. or GlaxoSmithKline plc?

Pfizer and GlaxoSmithKline are two names that generate a lot of interest among income investors. But which stock offers the best prospects for income-seeking investors over the long term?

Fri May 8

NL

Article

gbudwell published an article 11:55 AM

Why Shares of Flamel Technologies SA Bolted Higher Today

Shares of the French biopharma Flamel Technologies rose by more than 16% today. Here's why.

NL

Article

gbudwell published an article 11:21 AM

Why Shares of BioScrip, Inc. Are Crashing Today

Shares of the home infusion care services company BioScrip are cratering today. Here's why.

NL

Article

gbudwell published an article 7:35 AM

Forget Gilead Sciences, Inc. -- This Tiny Biotech Offers A Much Richer Opportunity

Sarepta Therapeutics is nearing the moment of truth for its Duchenne muscular dystrophy treatment eteplirsen. If all goes according to plan, this single drug could transform this tiny biotech into one of the best performing healthcare stocks in 2015. [more]

Wed May 6

NL

Article

gbudwell published an article 11:08 AM

Why Shares of Synageva BioPharma Corp. Skyrocketed Today

Shares of the rare disease drugmaker Synageva BioPharma exploded higher this morning. Here's why.

Sat May 2

NL

Article

gbudwell published an article 8:08 AM

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75225
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 3
Total Picks 9
Best Pick RXII (+9.56)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts